MA41643A - BRUTON TYROSINE KINASE INHIBITOR PHARMACEUTICAL FORMULATIONS - Google Patents

BRUTON TYROSINE KINASE INHIBITOR PHARMACEUTICAL FORMULATIONS

Info

Publication number
MA41643A
MA41643A MA041643A MA41643A MA41643A MA 41643 A MA41643 A MA 41643A MA 041643 A MA041643 A MA 041643A MA 41643 A MA41643 A MA 41643A MA 41643 A MA41643 A MA 41643A
Authority
MA
Morocco
Prior art keywords
tyrosine kinase
kinase inhibitor
pharmaceutical formulations
inhibitor pharmaceutical
bruton tyrosine
Prior art date
Application number
MA041643A
Other languages
French (fr)
Other versions
MA41643B1 (en
Inventor
Harisha Atluri
Ching Wah Chong
Robert Kuehl
Heow Tan
Original Assignee
Pharmacyclics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Llc filed Critical Pharmacyclics Llc
Priority claimed from PCT/US2016/020467 external-priority patent/WO2016141068A1/en
Publication of MA41643A publication Critical patent/MA41643A/en
Publication of MA41643B1 publication Critical patent/MA41643B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
MA41643A 2015-03-03 2016-03-02 PHARMACEUTICAL FORMULATIONS OF BRUTON'S TYROSINE KINASE INHIBITOR MA41643B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562127717P 2015-03-03 2015-03-03
PCT/US2016/020467 WO2016141068A1 (en) 2015-03-03 2016-03-02 Pharmaceutical formulations of bruton's tyrosine kinase inhibtor

Publications (2)

Publication Number Publication Date
MA41643A true MA41643A (en) 2018-01-09
MA41643B1 MA41643B1 (en) 2024-02-29

Family

ID=59254075

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41643A MA41643B1 (en) 2015-03-03 2016-03-02 PHARMACEUTICAL FORMULATIONS OF BRUTON'S TYROSINE KINASE INHIBITOR

Country Status (2)

Country Link
AR (1) AR103832A1 (en)
MA (1) MA41643B1 (en)

Also Published As

Publication number Publication date
AR103832A1 (en) 2017-06-07
MA41643B1 (en) 2024-02-29

Similar Documents

Publication Publication Date Title
ZA201907661B (en) Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor
IL255831A (en) Inhibitors of bruton's tyrosine kinase
IL250085A0 (en) Novel formulations of a bruton's tyrosine kinase inhibitor
EP3414234A4 (en) Bruton's tyrosine kinase inhibitors
ZA201805439B (en) Bruton's tyrosine kinase inhibitors
MA41350A (en) SUMMARY OF A BRUTON TYROSINE KINASE INHIBITOR
EP3174539A4 (en) Inhibitors of bruton's tyrosine kinase
EP3141546A4 (en) Inhibitor of bruton's tyrosine kinase
MA50541A (en) PHARMACEUTICAL FORMULATIONS
HK1258699A1 (en) Dosage form compositions comprising an inhibitor of bruton's tyrosine kinase
EP3159340A4 (en) New bruton's tyrosine kinase inhibitor
MA46867A (en) PHARMACEUTICAL FORMULATIONS
ZA201906887B (en) Bruton's tyrosine kinase inhibitors
MA42303A (en) PHARMACEUTICAL FORMULATIONS
ZA201903694B (en) Inhibitors of bruton's tyrosine kinase
MA54716A (en) REDUCTION OF THE VISCOSITY OF PHARMACEUTICAL FORMULATIONS
MA42510A (en) FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON TYROSINE KINASE
MA42509A (en) ADIPATE FORMS AND COMPOSITIONS OF BRUTON TYROSINE KINASE BIARYL INHIBITORS
MA49837A (en) PHARMACEUTICAL COMPOSITIONS
MA55015A (en) PHARMACEUTICAL FORMULATIONS
MA52629A (en) BRUTON TYROSINE KINASE INHIBITORS
MA42546A (en) BRUTON TYROSINE KINASE INHIBITOR COMBINATIONS AND THEIR USES
MA54095A (en) AQUEOUS PHARMACEUTICAL FORMULATIONS
MA46642A (en) KALLICREIN INHIBITOR MEDICINAL PRODUCTS
MA49625A (en) PHARMACEUTICAL COMPOSITIONS